Aristo Bio-Tech and Lifescience Limited (NSE:ARISTO)
India
· Delayed Price · Currency is INR 124.00
-4.25 (-3.31%)
At close: May 20, 2025
NSE:ARISTO Balance Sheet
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 | Mar '20 Mar 31, 2020 | 2019 |
| Cash & Equivalents | 7.81 | 54.13 | 38.03 | 26 | 1.12 | 5.25 | Upgrade
|
| Cash & Short-Term Investments | 7.81 | 54.13 | 38.03 | 26 | 1.12 | 5.25 | Upgrade
|
| Cash Growth | 7.14% | 42.32% | 46.25% | 2215.58% | -78.61% | 19.91% | Upgrade
|
| Accounts Receivable | 1,423 | 574.73 | 445.73 | 332 | 327.66 | 483.06 | Upgrade
|
| Other Receivables | - | - | 19.37 | - | - | - | Upgrade
|
| Receivables | 1,536 | 574.73 | 465.11 | 332 | 327.66 | 483.06 | Upgrade
|
| Inventory | 447.13 | 401.87 | 307.77 | 243.62 | 319.45 | 243.24 | Upgrade
|
| Prepaid Expenses | - | - | - | - | 0.51 | 0.47 | Upgrade
|
| Other Current Assets | 3.69 | 19.53 | 15.53 | 23.79 | 42.29 | 35.01 | Upgrade
|
| Total Current Assets | 1,995 | 1,050 | 826.44 | 625.42 | 691.03 | 767.02 | Upgrade
|
| Property, Plant & Equipment | 231.77 | 216.79 | 167.15 | 144.58 | 123.12 | 110.72 | Upgrade
|
| Other Intangible Assets | 0.01 | 0.01 | 0.01 | 0.02 | 0.03 | 0.03 | Upgrade
|
| Long-Term Deferred Tax Assets | - | - | 0.08 | - | - | 0.74 | Upgrade
|
| Other Long-Term Assets | 6.53 | 5.81 | 4.6 | -0 | - | - | Upgrade
|
| Total Assets | 2,233 | 1,273 | 998.29 | 770.02 | 814.17 | 878.51 | Upgrade
|
| Accounts Payable | 1,618 | 688.64 | 446.04 | 352.13 | 383.51 | 378.09 | Upgrade
|
| Accrued Expenses | 20.34 | 10.15 | 11.6 | 5.19 | 5.36 | 6.08 | Upgrade
|
| Short-Term Debt | 118.35 | 78.51 | 99.44 | 126.68 | 93.04 | 76 | Upgrade
|
| Current Portion of Long-Term Debt | - | 30.28 | 23.8 | 17.26 | 8.84 | 14.39 | Upgrade
|
| Current Income Taxes Payable | - | 13.87 | 12.62 | 4.74 | 3.45 | 4.06 | Upgrade
|
| Other Current Liabilities | 5.38 | 14.23 | 1.35 | 3.41 | 65.53 | 170.13 | Upgrade
|
| Total Current Liabilities | 1,763 | 835.68 | 594.86 | 509.39 | 559.73 | 648.75 | Upgrade
|
| Long-Term Debt | 84.78 | 99.96 | 101.66 | 110.91 | 120.6 | 106.71 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 3.91 | 1.14 | - | 0.86 | 0.04 | - | Upgrade
|
| Other Long-Term Liabilities | 0 | 0 | 0.22 | 0.2 | 0 | - | Upgrade
|
| Total Liabilities | 1,851 | 936.78 | 696.74 | 621.36 | 680.37 | 755.46 | Upgrade
|
| Common Stock | 68.08 | 68.08 | 68.08 | 49.95 | 49.95 | 49.95 | Upgrade
|
| Retained Earnings | - | - | - | 98.71 | 83.86 | 73.1 | Upgrade
|
| Comprehensive Income & Other | 313.54 | 268.01 | 233.48 | - | - | - | Upgrade
|
| Shareholders' Equity | 381.62 | 336.09 | 301.55 | 148.66 | 133.81 | 123.05 | Upgrade
|
| Total Liabilities & Equity | 2,233 | 1,273 | 998.29 | 770.02 | 814.17 | 878.51 | Upgrade
|
| Total Debt | 203.13 | 208.76 | 224.9 | 254.84 | 222.48 | 197.1 | Upgrade
|
| Net Cash (Debt) | -195.33 | -154.63 | -186.87 | -228.84 | -221.35 | -191.85 | Upgrade
|
| Net Cash Per Share | -28.69 | -22.71 | -35.25 | -45.81 | -44.32 | -38.41 | Upgrade
|
| Filing Date Shares Outstanding | 6.81 | 6.81 | 6.81 | 5 | 5 | 5 | Upgrade
|
| Total Common Shares Outstanding | 6.81 | 6.81 | 6.81 | 5 | 5 | 5 | Upgrade
|
| Working Capital | 232.01 | 214.57 | 231.59 | 116.02 | 131.3 | 118.27 | Upgrade
|
| Book Value Per Share | 56.07 | 49.37 | 44.30 | 29.76 | 26.79 | 24.63 | Upgrade
|
| Tangible Book Value | 381.61 | 336.08 | 301.54 | 148.64 | 133.78 | 123.02 | Upgrade
|
| Tangible Book Value Per Share | 56.07 | 49.37 | 44.29 | 29.76 | 26.78 | 24.63 | Upgrade
|
| Land | - | 56.24 | 56.24 | 56.24 | 33.83 | 33.83 | Upgrade
|
| Buildings | - | 110.72 | 62.78 | 61.01 | 73.94 | 40.26 | Upgrade
|
| Machinery | - | 134.94 | 108.3 | 82.13 | 60.98 | 46.61 | Upgrade
|
| Construction In Progress | - | - | 10.97 | 0.98 | - | 28.15 | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.